The G-BA Innovation Committee recommends transfer to standard care for two projects in Germany

11

May 2022

On April 4, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions which recommended the transfer to standard care for two completed projects. The projects relate to the management of rare diseases and the strengthening of the regional healthcare structures and processes.

A short overview of the projects is provided below:

  • “TRANSLATE-NAMSE: better care for people living with rare diseases” project was aimed to speed up diagnosis and ensure the proper care of patients with rare congenital diseases through the coordinated collaboration of centers for rare diseases. The structures and processes proposed by NAMSE were to be introduced and sustainably implemented in nine centers for rare diseases. Through case management integrating national expertise and enabling providers to access the data from the centers involved, it was aimed to shorten the time for diagnosis and obtain the respective treatment;
  • “IGIB-StimMT - Structural migration in the middle area of Templin” project aimed to adapt the regional healthcare structures and processes in the middle area of Templin to the conditions of demographic change in a needs-oriented and region-specific manner. An outpatient-inpatient center was set up in Templin for this purpose. The inpatient and outpatient care capacities were adjusted and interlinked across disciplines and institutions. This took place on several levels and included the established medical practices, the hospital, and nursing care, supplemented by establishing a coordination and advice center for individual consultations and support for patients. The project integrated outpatient, inpatient, and nursing care, as well as other health care offers.

Innovation Fund is a vital instrument to propose and test a novel model of care (including the ones in the form of selective contracts). If the model proves valuable, it can be a subject for further dissemination in the country.

The full details in German can be found here, here (TRANSLATE-NAMSE project), and here (IGIB-StimMT project).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

18

May 2022

On April 19, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has informed of the favorable results of the scientific evaluation of the G-BA Innovation Fund performed by the economic research center Prognos AG.

Read more

05

May 2022

In March and April 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty-three health apps are now available at the DiGA Directory.

Read more

02

May 2022

On April 4, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced funding from the G-BA Innovation Fund for 18 innovative healthcare research projects dedicated to medical guidelines.

Read more

26

Apr 2022

The revised EBM (German Uniform Evaluation Standard) catalog came into force on April 1, 2022. The most significant changes concern the introduction of new additional flat rates for the observation and care of patients who are given certain medications, adjustment of EBM reproductive medicine definitions, and inclusion of several new codes for PET and PET/CT.

Read more

13

Apr 2022

On March 3, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for new forms of care. A total of seven prioritized topics are defined. The preparation of a complete application can be supported for a period of up to six months with a grant of up to a maximum of €75,000. The deadline for submitting ideas is May 17, 2022, at noon.

Read more